Capital Markets
Massachusetts
7 years ranked
Provided by Latham & Watkins LLP
Peter Handrinos advises boards of directors, management teams, and entrepreneurs on corporate and securities law matters, with an emphasis on mergers and acquisitions and financing transactions for life sciences and technology companies. Over his 25-year career, he has advised many of the most prominent pharmaceutical, biotechnology, and medical device companies in the healthcare industry.
Pete is recognized internationally for his leadership in the life sciences industry. He was named as the Corporate Attorney of the Year by LMG Life Sciences in 2021. He has been recognized for over 20 years as a leader in Life Sciences.
Provided by Chambers
Peter Handrinos draws widespread praise for his extensive experience advising on IPOs and other high value capital markets transactions. He counts global financial institutions and pharmaceutical companies among his clients.
Peter Handrinos offers substantial expertise in capital markets transactions involving life sciences companies. He has notable experience in M&A and financings.
Peter Handrinos draws widespread praise for his extensive experience advising on IPOs and other high value capital markets transactions. He counts global financial institutions and pharmaceutical companies among his clients.
Provided by Chambers
Peter is a strategic, pragmatic problem-solver.
Peter is very strategic, pragmatic and a problem-solver.
Chambers is the leading data and intelligence partner for the legal sector.